返回
Exacerbation-Prone Asthma
DOI:10.1016/j.jaip.2019.11.009.png)
摘要
En 中文
Patients who are prone to exacerbations of asthma experience significant costs in terms of missed work and school, acute care visits, and hospitalizations. Exacerbations are largely driven by environmental exposures including pollutants, stress, and viral and bacterial pathogens. These exposures are most likely to induce acute severe asthma attacks in high-risk patients. These personal risk factors for exacerbations can vary with the phenotype of asthma and age of the patient. In children, allergic sensitization is a strong risk factor, especially for those children who develop sensitization early in life. Airway inflammation is an important risk factor, and biomarkers are under evaluation for utility in detecting eosinophilic and type 2 inflammation and neutrophilic inflammation as indicators of risk for recurrent exacerbations. Insights into inflammatory mechanisms have led to new approaches to prevent exacerbations using mAb-based biologics that target specific type 2 pathways. Challenges remain in developing an evidence base to support precision interventions with these effective yet expensive therapies, and in determining whether these treatments will be safe and effective in young children. Unfortunately, there has been less progress in developing treatments for acute exacerbations. Hopefully, greater understanding of mechanisms relating airway viruses, bacteria, mucin production, and neutrophilic inflammatory responses will lead to additional treatment options for patients experiencing acute exacerbations. (C) 2019 American Academy of Allergy, Asthma & Immunology
Keyword:
Exacerbation-prone asthma
Precision interventions
Corticosteroids
Type 2 inflammation
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
6.6
论文数:
5.3K
被引数:
1.6W
机构
引用论文
Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbationNETosis释放的宿主DNA促进鼻病毒诱导的2型过敏性哮喘加重
NATURE MEDICINE
IF50
Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma
RESPIRATORY MEDICINE
IF3.1


